GOLIVER THERAPEUTICS is a spin-off from the INSERM and University of Nantes (CRTI UMR1064-ITUN-Nantes Hospital), focused on developing cell-based Advanced Therapy Medicinal Products (ATMP) to respond to an urgent unmet medical need in transplantation.

GOLIVER THERAPEUTICS aims to become a Worldwide leader in regenerative medicine in providing the first cell-based therapy product for life-threatening liver failures.

Date of creation : 2017, spin-off from the INSERM and Nantes Université.